1 |
AHMAD E, LIM S, LAMPTEY R, et al. Type 2 diabetes[J]. Lancet, 2022,400(10365):1803-1820. doi:10.1016/s0140-6736(22)01655-5
doi: 10.1016/s0140-6736(22)01655-5
|
2 |
SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract,2022,183:109-119. doi:10.1016/j.diabres.2023.110945
doi: 10.1016/j.diabres.2023.110945
|
3 |
YANPING W, GAO X, CHENG Y, et al. The interaction between obesity and visceral hypersensitivity[J]. J Gastroenterol Hepatol,2023,38(3):370-377. doi:10.1111/jgh.16083
doi: 10.1111/jgh.16083
|
4 |
RUZE R, LIU T, ZOU X, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments[J]. Front Endocrinol (Lausanne),2023,14:1161521. doi:10.3389/fendo.2023.1161521
doi: 10.3389/fendo.2023.1161521
|
5 |
NEELAND I J, ROSS R, DESPRÉS J P, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol,2019,7(9):715-725. doi:10.1016/s2213-8587(19)30084-1
doi: 10.1016/s2213-8587(19)30084-1
|
6 |
WANG M, LUO Y, CAI H, et al. Prediction of type 2 diabetes mellitus using noninvasive MRI quantitation of visceral abdominal adiposity tissue volume[J].Quant Imaging Med Surg,2019,9(6):1076-1086. doi:10.21037/qims.2019.06.01
doi: 10.21037/qims.2019.06.01
|
7 |
HEBER S D, HETTERICH H, LORBEER R,et al. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease[J]. PLoS One,2017,12(5):e0177154. doi:10.1371/journal.pone.0177154
doi: 10.1371/journal.pone.0177154
|
8 |
ZHENG Y, YANG S, CHEN X,et al. The Correlation between Type 2 Diabetes and Fat Fraction in Liver and Pancreas: A Study using MR Dixon Technique[J]. Contrast Media Mol Imaging,2022,2022:7073647. doi:10.1155/2022/7073647
doi: 10.1155/2022/7073647
|
9 |
YI J, XU F, LI T, et al. Quantitative study of 3T MRI qDixon-WIP applied in pancreatic fat infiltration in patients with type 2 diabetes mellitus[J]. Front Endocrinol (Lausanne),2023,14:1140111. doi:10.3389/fendo.2023.1140111
doi: 10.3389/fendo.2023.1140111
|
10 |
KIEFER L S, FABIAN J, ROSPLESZCZ S, et al. Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes, prediabetes and healthy controls from the general population[J]. Eur J Radiol,2018,105:261-268. doi:10.1016/j.ejrad.2018.06.023
doi: 10.1016/j.ejrad.2018.06.023
|
11 |
SHEN W, WANG Z, TANG H, et al. Volume estimates by imaging methods: model comparisons with visible woman as the reference[J]. Obes Res,2003,11(2):217-225. doi:10.1038/oby.2003.34
doi: 10.1038/oby.2003.34
|
12 |
LONGO M, ZATTERALE F, NADERI J, et al Adipose tissue dysfunction as determinant of obesity-associated metabolic complications[J]. Int J Mol Sci,2019,20(9):2358. doi:10.3390/ijms20092358
doi: 10.3390/ijms20092358
|
13 |
DIN M, AHMED B A, SYED S A, et al. Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults[J]. J Clin Endocrinol Metab,2023:dgad604. doi:10.1210/clinem/dgad604
doi: 10.1210/clinem/dgad604
|
14 |
范慧芳,陈强,原小军,等. 磁共振IDEAL-IQ技术对急性胰腺炎患者脂肪与铁沉积的诊断效能分析[J]. 临床肝胆病杂志,2022,38(10):2320-2324. doi:10.3969/j.issn.1001-5256.2022.10.022
doi: 10.3969/j.issn.1001-5256.2022.10.022
|
15 |
SHEN W, MIDDLETON M S, CUNHA G M, et al. Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis[J]. J Hepatol,2023,78(2):238-246. doi:10.1016/j.jhep.2022.10.027
doi: 10.1016/j.jhep.2022.10.027
|
16 |
NEELAND I J, ROSS R, DESPRÉS J P, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement[J]. Lancet Diabetes Endocrinol,2019,7(9):715-725. doi:10.1016/s2213-8587(19)30084-1
doi: 10.1016/s2213-8587(19)30084-1
|
17 |
WANG Q, YE F, MA P, et al. Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed[J]. J Int Med Res, 2019,47(5):1958-1974. doi:10.1177/0300060519836033
doi: 10.1177/0300060519836033
|
18 |
柴军,刘朋,洪旭,等. 化学位移MRI对初诊2型糖尿病患者及健康人胰腺脂肪含量的比较研究[J]. 磁共振成像,2015,6(3):208-212. doi:10.3969/j.issn.1674-8034.2015.03.010
doi: 10.3969/j.issn.1674-8034.2015.03.010
|
19 |
曾文彦,孙慧琳,庄娘妥,等. 3.0T磁共振IDEAL-IQ技术量化评价2型糖尿病患者胰腺脂肪沉积及铁沉积的价值[J]. 国际医药卫生导报,2019,25(13):2027-2030. doi:10.3760/cma.j.issn.1007-1245.2019.13.004
doi: 10.3760/cma.j.issn.1007-1245.2019.13.004
|
20 |
王骏,郝金华,梁羡和. MRI定量分析肝、胰脂肪含量与糖耐量的相关性[J]. 国际医药卫生导报,2022,28(19):2740-2743. doi:10.3760/cma.j.issn.1007-1245.2022.19.017
doi: 10.3760/cma.j.issn.1007-1245.2022.19.017
|
21 |
梁伟强,彭振鹏,高进云,等. 磁共振胰腺脂肪定量测定预测糖耐量异常及2型糖尿病[J]. 中山大学学报(医学科学版),2021,42(2):250-256.
|
22 |
吴海霞,李俊霞. 阿卡波糖治疗2型糖尿病合并非酒精性脂肪肝病疗效观察[J]. 实用糖尿病杂志,2014,10(2):32-33.
|
23 |
BAI J, GAO C, LI X, et al. Correlation analysis of the abdominal visceral fat area with the structure and function of the heart and liver in obesity: a prospective magnetic resonance imaging study[J]. Cardiovasc Diabetol,2023,22(1):206. doi:10.1186/s12933-023-01926-0
doi: 10.1186/s12933-023-01926-0
|
24 |
白川民,杨会军,吴斌. 脂肪因子Adipsin与2型糖尿病相关性的研究进展[J]. 实用医学杂志,2023,39(2):133-136. doi:10.3969/j.issn.1006-5725.2023.02.001
doi: 10.3969/j.issn.1006-5725.2023.02.001
|
25 |
王雨竹,郁万江,李烁,等. 定量CT测量超重/肥胖人群胰腺脂肪含量及其与2型糖尿病的相关性[J]. 中国医学影像学杂志,2022,30(6):620-624. doi:10.3969/j.issn.1005-5185.2022.06.019
doi: 10.3969/j.issn.1005-5185.2022.06.019
|
26 |
邬倩,高玉敏,李乌云塔娜,等. 蒙古族瘦素受体、脂联素受体基因多态性与2型糖尿病交互作用研究[J]. 实用医学杂志,2022,38(1):57-61. doi:10.3969/j.issn.1006-5725.2022.01.011
doi: 10.3969/j.issn.1006-5725.2022.01.011
|
27 |
AN Q, ZHANG Q H, WANG Y,et al. Association between type 2 diabetes mellitus and body composition based on MRI fat fraction mapping[J]. Front Public Health,2024,12:1332346. doi:10.3389/fpubh.2024.1332346
doi: 10.3389/fpubh.2024.1332346
|